PEGylation is a common method to improve peptide stability and bioavailability. Thanks to decades of experience in peptide modification and synthesis, CD Formulation provides a wide range of PEGylation services. Our team has the expertise and knowledge to customize different PEGylation strategies for our customers to meet specific research and application needs.
The covalent attachment of polyethylene glycol (PEG) to a peptide chain is called peptide PEGylation. Due to the enhanced therapeutic properties of PEGylated peptides, improved peptide stability, and bioavailability, this conjugation mechanism may be a solution to overcome many challenges faced by peptide drug candidates.
Fig. 1 Schematic diagram of PEG–peptide conjugates. (Hamley IW, et al., 2014)
As experts in peptide modification, CD Formulation provides unparalleled peptide PEGylation services to clients around the world. We have reliable synthesis procedures and superior peptide analysis technologies to address any possible challenges in the development and production of peptide therapeutics.
Our team of peptide modification experts can perform site-specific PEGylation at different sites of the peptide, including:
This modification is achieved by direct polyethylene glycol carboxylic acid coupling or chemical connection of polyethylene glycol thioesters to cysteine residues.
C-terminal PEGylation is a more complex process, mainly achieved by thiocarboxylic acid modification and sulfonyl-azide PEG reagents. In addition, hydrazide combined with acetone acylating reagents is another C-terminal PEGylation method.
In addition to the N-terminus and C-terminus, amino acid chains with appropriate functional groups can be PEGylated.
PEG and peptides are usually conjugated via amide bond formation, but other linkage chemistries are possible, such as thiol-maleimide, oxime linkage, and click chemistry. To ensure site-specific PEGylation, we typically use the following 3 methods:
This reaction occurs between the azide group of the PEG reagent and the alkyne group of the peptide (such as Huisgen 1,3-coupling reaction), which can achieve highly selective and efficient PEGylation. This method can ensure the connection of PEG to the peptide at a specific site.
Specific amino acid residues such as lysine, aspartic acid, etc., are used to connect polyethylene glycol (PEG) to peptides. Site-specific connection is achieved by introducing functionalized amino acids at specific sites of the peptide chain.
Bioorthogonal chemical reactions, such as thiol-maleimide reaction and oxime reaction, are used to selectively carry out PEG modification on specific amino acids. These reactions usually don't occur under in vivo conditions and therefore have better biocompatibility.
PEG and its derivatives are nonionic, nontoxic, biocompatible, and highly hydrophilic polymers that have been widely used in custom peptide synthesis to improve the solubility of hydrophobic peptides, increase the bioavailability of bioactive peptides, and protect peptides from eliciting immune responses. Regulatory approvals have been granted for PEGylated drugs with varying PEG chain lengths, ranging in molecular weight from 5 -40 kDa.
PEGs are mainly classified into two categories:
![]() m-PEG2-amine |
![]() azido-PEG2-amine |
![]() propargyl-PEG2-amine |
![]() amino-PEG2-amine |
![]() amino-PEG2-acid |
![]() PEG8 |
![]() biotin-PEG2-amine |
![]() mini-PEG3 |
![]() Custom PEGs |
In addition to peptide synthesis capabilities, CD Formulation combines flexible GMP manufacturing facilities with cutting-edge peptide analytical knowledge to provide a full range of quality control testing services to accelerate the commercialization of your products, including:
Published Data
Technology: PEGylated SAAP-148 Peptide Synthesis
Journal: J Innate Immun.
IF: 4.7
Published: 2023
Results:
The authors designed and synthesized a library of SAAP-148 peptides linked to polyethylene glycol (PEG) groups of varying lengths at either the N-terminal or C-terminal sites. The peptides were screened for hemolytic activity and antimicrobial activity against planktonic Staphylococcus aureus and Escherichia coli and biofilm-resident Acinetobacter baumannii. The results showed that the PEGylated SAAP-148 variants can significantly enhance antimicrobial activity and reduce hemolysis compared to SAAP-148.
Fig. 2 Set of PEGylated SAAP-148, LL-37, or CMV-1 peptides used in this study. (van Gent ME, et al., 2023)
CD Formulation has extensive experience with each PEGylation peptide modification. Please don't hesitate to contact us if you are interested in our services, and to learn more about the possibilities of incorporating PEG into your peptides. We look forward to cooperating with you.
References